HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Korean study confirms BESPONSA's safety in tough blood cancer
Disease control CompletedThis study monitored 108 Korean patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) who received BESPONSA. The main goal was to track side effects and see how well the drug worked in real-world settings. Results help confirm the drug's safety and effect…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New drug shows promise in preventing Graft-Versus-Host disease
Disease control CompletedThis early study tested the drug belimumab (Benlysta) to see if it could prevent chronic graft-versus-host disease (GvHD) in 10 adults who had a stem cell transplant for blood cancer. GvHD is a serious condition where the donor's immune cells attack the patient's body. The main g…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New radiation technique aims to safely prepare blood cancer patients for transplant
Disease control CompletedThis study tested a new way to deliver total body radiation to adults with blood cancers who need a stem cell transplant. The goal was to see if this method could effectively target cancer while protecting the lungs. 36 patients took part, and the study focused on safety and how …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Talking away the tiredness: CBT tackles Post-Transplant fatigue
Symptom relief CompletedThis study looked at whether a type of talk therapy called cognitive-behavioral therapy (CBT) can help reduce the severe tiredness that many people feel after a stem cell transplant for blood cancer. 66 adults who had a transplant at least 6 months earlier and still had significa…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 18, 2026 11:47 UTC
-
Home transfusions for blood cancer patients: a new comfort option?
Symptom relief CompletedThis study looked at whether giving blood transfusions at home is practical and acceptable for people with advanced blood cancers who have a life expectancy of six months or less. Ten patients were enrolled to see how many would agree to join, complete their home transfusions, an…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 17, 2026 12:09 UTC
-
New drug may ease severe skin rashes in cancer patients
Symptom relief CompletedThis study tested whether the drug benralizumab can safely reduce skin rashes caused by cancer treatments like checkpoint inhibitors. The goal was to lower the number of high-grade rashes to milder ones, which could improve quality of life and help patients stay on their cancer t…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 17, 2026 12:07 UTC
-
Blood transfusions unlock hospice access for blood cancer patients
Symptom relief CompletedThis study tested a new way to help people with blood cancers (like leukemia or lymphoma) get into hospice care earlier. Normally, hospice doesn't cover blood transfusions, so patients delay hospice to keep getting them. The study paid for transfusions while patients were on hosp…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Adam Olszewski • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
HIIT and weights show promise for stem cell recovery
Symptom relief CompletedThis study looked at whether 12 weeks of high-intensity interval training (HIIT) and resistance training could help people who had a stem cell transplant for blood cancer. It involved 16 patients and their caregivers. The goal was to see if exercise improves physical function, th…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 12, 2026 12:07 UTC
-
Blood markers may predict dangerous transplant complication
Knowledge-focused CompletedThis study looked at 70 patients who had a stem cell transplant for blood cancer. Researchers measured levels of complement proteins in the blood to see if they are linked to graft-versus-host disease, a common and serious side effect. The goal is to better understand how inflamm…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:56 UTC
-
COVID-19 vaccine study in young cancer and transplant patients completed
Knowledge-focused CompletedThis study looked at how well COVID-19 vaccines work in 21 children and young adults (under 24) with cancer or who had a transplant or cellular therapy. Researchers measured antibody and T-cell responses after vaccination. The goal was to understand vaccine effectiveness in these…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC
-
Scientists map hidden germs in kids with cancer
Knowledge-focused CompletedThis study looked at the tiny organisms (bacteria and fungi) living in the mouth and nose of children with leukemia or those getting a bone marrow transplant. Researchers wanted to see how these germ communities change during chemotherapy. The goal was to learn more, not to test …
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC
-
Study aims to uncover hidden hormone problems in ICU patients
Knowledge-focused CompletedThis study looked at how the adrenal glands work in people who are critically ill, such as those with sepsis. The goal was to better understand a condition called adrenal insufficiency, where the body doesn't make enough stress hormones. Researchers measured hormone levels in 225…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:07 UTC
-
Heart defects may worsen outcomes for childhood cancer survivors
Knowledge-focused CompletedThis study looked at 800 children who survived blood cancer to see if having a congenital heart defect raises their risk of death or other health problems later in life. Researchers also checked for shared genes between the two conditions. The goal is to better understand and pre…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
Study reveals vaccine response gap in immunocompromised individuals
Knowledge-focused CompletedThis study looked at how well the Pfizer COVID-19 vaccine triggers an immune response in 196 adults with weakened immune systems (like kidney transplant patients or those with cancer) compared to healthy adults. Researchers measured antibody levels and their ability to fight the …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
App vs. paper: which diary boosts cancer pill adherence?
Knowledge-focused CompletedThis study tested whether an electronic diary app helps cancer patients take their oral medications more consistently than a traditional paper diary. A total of 124 adults with solid tumors or blood cancers were randomly assigned to use either the app or a paper diary to track th…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:05 UTC